Back

Period2-mediated downregulation of ERK/MAPK phosphorylation in nasopharyngeal carcinoma

zhang, z.; Ma, Z.; Kang, J.; Yang, J.; Xu, Q.; Niu, X.; Luo, X.; Wang, J.; Li, H.; Hou, L.

2023-08-09 otolaryngology
10.1101/2023.08.06.23293720
Show abstract

Withdrawal statementThe authors have withdrawn their manuscript owing to because authors want to do further study about period2-mediated downregulation of ERK/MAPK phosphorylation in nasopharyngeal carcinoma. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
● based on 1737 papers
Top 31%
15.5%
2
Cancers
○ based on 57 papers
Top 1.0%
13.3%
3
Cells
○ based on 14 papers
Top 0.1%
12.6%
4
Frontiers in Oncology
○ based on 34 papers
Top 0.5%
11.3%
50% of probability mass above
5
Frontiers in Immunology
○ based on 140 papers
Top 0.5%
10.2%
6
Journal of Clinical Medicine
○ based on 77 papers
Top 2%
5.3%
7
Cureus
○ based on 64 papers
Top 4%
4.5%
8
Scientific Reports
○ based on 701 papers
Top 64%
2.3%
9
iScience
○ based on 74 papers
Top 2%
2.3%
10
Medicine
○ based on 29 papers
Top 4%
1.8%
11
Biomedicines
○ based on 21 papers
Top 1%
1.6%
12
International Journal of Molecular Sciences
○ based on 39 papers
Top 2%
1.3%
13
Applied Sciences
○ based on 10 papers
Top 0.9%
1.2%
14
Frontiers in Pharmacology
○ based on 27 papers
Top 3%
1.2%
15
Sleep Medicine
○ based on 11 papers
Top 1%
1.2%
16
British Journal of Cancer
○ based on 22 papers
Top 3%
1.2%
17
Frontiers in Neurology
○ based on 74 papers
Top 12%
0.7%